Condition: Myopia · Sponsor: Ohio State University
The aims of this clinical trial will test whether or not the onset of nearsightedness is delayed in a group of children randomized to nightly drops in 0.05% atropine in both eyes, in comparison to children who receiving nightly placebo drops in both eyes. The primary outcome is the two-year cumulative incidence of nearsightedness. The second aim of this project will determine whether atropine is associated with slower eye growth in children receiving nightly drops of atropine versus placebo.
This description comes directly from the study's public registry record.
Lisa A Jordan, PhD · 614-247-7321 · jordan.646@osu.edu
Always discuss trial participation with your own doctor first.
| University of Alabama School of Optometry | Birmingham, Alabama, United States | Recruiting |
| University of California, Berkeley, School of Optometry | Berkeley, California, United States | Not Yet Recruiting |
| Southern California College of Optometry at Marshall B. Ketchum University | Fullerton, California, United States | Recruiting |
| Stanford University | Palo Alto, California, United States | Not Yet Recruiting |
| Illinois College of Optometry | Chicago, Illinois, United States | Recruiting |
| Indiana University | Bloomington, Indiana, United States | Recruiting |
| New England College of Optometry | Boston, Massachusetts, United States | Recruiting |
| State University of New York College of Optometry | New York, New York, United States | Not Yet Recruiting |
| Case Western Reserve Department of Ophthalmology | Cleveland, Ohio, United States | Not Yet Recruiting |
| The Ohio State University College of Optometry | Columbus, Ohio, United States | Recruiting |
| Pennsylvania College of Optometry at Drexel University | Elkins Park, Pennsylvania, United States | Not Yet Recruiting |
| Southern College of Optometry | Memphis, Tennessee, United States | Not Yet Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07567040